CDC Forced to Admit It Doesn’t Collect Data on Natural Immunity to COVID

In response to a Freedom of Information Act request, the Centers for Disease and Control said it has no record of an individual previously infected with COVID becoming reinfected or transmitting the virus to others — because the agency doesn’t collect that data.

By Michael Nevradakis, Ph.D.

Source: https://childrenshealthdefense.org/defender/cdc-data-natural-immunity-covid

Miss a day, miss a lot. Subscribe to The Defender’s Top News of the Day. It’s free.

The Centers for Disease Control (CDC), in response to a Freedom of Information Act (FOIA) request, said it has no record of an individual previously infected with COVID becoming reinfected and transmitting the virus to others.

The FOIA request, submitted Sept. 2 by attorney Aaron Siri of the Siri & Glimstad law firm on behalf of the Informed Consent Action Network (ICAN), sought the following information:

“Documents reflecting any documented case of an individual who: (1) never received a COVID vaccine; (2) was infected with COVID once, recovered, and then later became infected again; and (3) transmitted SARS-CoV-2 to another person when reinfected.”

The CDC responded Nov. 5, stating:

“A search of our records failed to reveal any documents pertaining to your request. The CDC Emergency Operations Center (EOC) conveyed that this information is not collected.”

According to Siri, the revelation that the CDC does not collect data on people who have acquired natural immunity to the virus raises questions about vaccine mandates, specifically how the the government, or employers can mandate vaccines for people who may not need them and who could be at a greater-than-average risk of experiencing an adverse reaction to the shots.

In a blog post, Siri wrote:

“… yet the CDC is actively crushing the rights of millions of naturally immune individuals in this country if they do not get the vaccine on the assumption they can transmit the virus. But despite clear proof the vaccinated spread the virus, the CDC lifts restrictions on the vaccinated?! That is dystopian.”

Siri added:

“Every single peer reviewed study has found that the naturally immune have far greater than 99% protection from having COVID, and this immunity does not wane. In contrast, the COVID vaccine provides, at best, 95% protection and this immunity wanes rapidly. I am no mathematician, but a constant 99% seems preferable to a 95% that quickly drops.”

The response from the CDC came as part of a broader exchange between the agency and Siri’s law firm, dating back to this past summer, in which ICAN and Siri’s law firm submitted a citizen’s petition to the CDC calling for restrictions on those individuals with natural immunity to be lifted.

What do the data show?

As far back as last year, CDC Director Rochelle Walensky, argued, “there is no evidence for lasting protective immunity to SARS-CoV-2 following natural infection.”

Yet data collected from numerous studies show just the opposite of what the CDC and public health authorities claim in their far-reaching vaccination campaign. In fact, many studies show individuals who have acquired natural immunity demonstrate a stronger and longer-lasting level of immunity and a decreased likelihood to transmit COVID to others.

The Brownstone Institute, founded in May 2021 in response to “the global crisis created by policy responses to the COVID-19 pandemic of 2020,” documented 81 peer-reviewed scientific studies which all come to the same conclusion: Natural immunity confers more effective and longer-lasting protection against COVID than vaccine-induced immunity.

The same institute previously documented 30 peer-reviewed scientific studies on natural immunity in relation to COVID infection.

Further examples abound. For instance, the Cleveland Clinic in June published a preprint study showing individuals previously infected with COVID were less likely to be reinfected than fully vaccinated individuals who never contracted the virus.

The authors of the Cleveland Clinic study concluded vaccination provides no additional benefit to those who already have acquired natural immunity.

In another recent preprint study, conducted by Israeli researchers, individuals fully vaccinated with the Pfizer-BioNTech vaccine were found to be 6 to 13 times more likely to be infected with the Delta variant as compared to those with natural immunity.

The FOIA request filed Siri’s law firm on behalf of ICAN and provided data from numerous other global studies, supported by a group of expert witnesses, including:

• Research conducted by the National Institutes of Health examined the likelihood of reinfection in people carrying antibodies against COVID, collecting data from more than 3.2 million people who had undergone antibody testing. Researchers found those individuals with antibodies became less likely to test positive for COVID as time went on.

The authors of the study wrote: “The data from this study suggest that people who have a positive result from a commercial antibody test appear to have substantial immunity to SARS-CoV-2, which means they may be at lower risk for future infection.”

• Official UK government data show a probable reinfection rate of 0.025%, but a vaccine breakthrough rate of 23% for Delta variant infections.
• An Irish review of 11 cohort studies involving more than 600,000 individuals who recovered from COVID found, in all studies, reinfection was “an uncommon event,” adding that there was “no study reporting an increase in the risk of reinfection over time.”
• Israel is one of the global leaders in overall vaccination against COVID. Nevertheless, research by the Israeli Health Ministry found vaccinated individuals had 6.72 times the rate of infection as compared to those that had previously contracted COVID.
• Another Israeli study found the naturally immune had a higher rate of protection against infection, hospitalization and severe illness as compared to those who were vaccinated.
• In Barnstable County, Massachusetts, despite a 69% vaccination coverage rate among its eligible residents at the time of the study, the CDC found 74% of those infected in a COVID outbreak were fully vaccinated for COVID, and the vaccinated had, on average, a higher presence of the virus in their nasal cavity than the unvaccinated who were infected.
• Following a COVID outbreak among employees of a gold mine in French Guiana, findings showed no employees with a previous history of infection were reinfected, while 63.2% of employees with no previous history of infection ended up contracting the virus.
• Findings from researchers at the NYU School of Medicine showed “[i]n COVID patients, immune responses were characterized by a highly augmented interferon response which was largely absent in vaccine recipients.”
• Researchers at Aarhus University Hospital in Denmark studied the immune response following COVID infections, finding the overwhelming majority of individuals who had recovered from infection had detectable, functional SARS-CoV2 spike-specific adaptive immune responses, making vaccination for any of them redundant.
• Yale University researchers determined that “plasma from previously infected vaccinated individuals displayed overall better neutralization capacity when compared to plasma from uninfected individuals that also received two vaccine doses.”
• University of California researchers concluded “[n]atural infection induced expansion of larger CD8 T cell clones occupied distinct clusters, likely due to the recognition of a broader set of viral epitopes presented by the virus not seen in the mRNA vaccine.”
• A study conducted by the CDC and the Wisconsin’s Department of Health Services evaluated the shedding of infectious COVID and observed high viral load in 68% of fully vaccinated individuals and in 63% of unvaccinated individuals. This demonstrates that those who are vaccinated will not only shed virus, but also will do so at the same rate as the unvaccinated. Most notably, this study did not identify anyone with prior natural infection that had any viral load.
• Researchers at Osaka University found “the SARS-CoV-2 Delta variant is poised to acquire complete resistance to wild-type spike vaccines.”
• Washington University School of Medicine researchers determined “[p]eople who recover [even] from mild COVID have bone-marrow cells that can churn out antibodies for decades.”

THE BMJ – Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial

Source: https://www.bmj.com/content/375/bmj.n2635

PDF: https://www.bmj.com/content/bmj/375/bmj.n2635.full.pdf

Feature BMJ Investigation

Revelations of poor practices at a contract research company helping to carry out Pfizer’s pivotal covid-19 vaccine trial raise questions about data integrity and regulatory oversight. Paul D Thacker reports

In autumn 2020 Pfizer’s chairman and chief executive, Albert Bourla, released an open letter to the billions of people around the world who were investing their hopes in a safe and effective covid-19 vaccine to end the pandemic. “As I’ve said before, we are operating at the speed of science,” Bourla wrote, explaining to the public when they could expect a Pfizer vaccine to be authorised in the United States.1

But, for researchers who were testing Pfizer’s vaccine at several sites in Texas during that autumn, speed may have come at the cost of data integrity and patient safety. A regional director who was employed at the research organisation Ventavia Research Group has told The BMJ that the company falsified data, unblinded patients, employed inadequately trained vaccinators, and was slow to follow up on adverse events reported in Pfizer’s pivotal phase III trial. Staff who conducted quality control checks were overwhelmed by the volume of problems they were finding. After repeatedly notifying Ventavia of these problems, the regional director, Brook Jackson, emailed a complaint to the US Food and Drug Administration (FDA). Ventavia fired her later the same day. Jackson has provided The BMJ with dozens of internal company documents, photos, audio recordings, and emails.

Poor laboratory management

On its website Ventavia calls itself the largest privately owned clinical research company in Texas and lists many awards it has won for its contract work.2 But Jackson has told The BMJ that, during the two weeks she was employed at Ventavia in September 2020, she repeatedly informed her superiors of poor laboratory management, patient safety concerns, and data integrity issues. Jackson was a trained clinical trial auditor who previously held a director of operations position and came to Ventavia with more than 15 years’ experience in clinical research coordination and management. Exasperated that Ventavia was not dealing with the problems, Jackson documented several matters late one night, taking photos on her mobile phone. One photo, provided to The BMJ, showed needles discarded in a plastic biohazard bag instead of a sharps container box. Another showed vaccine packaging materials with trial participants’ identification numbers written on them left out in the open, potentially unblinding participants. Ventavia executives later questioned Jackson for taking the photos.

Early and inadvertent unblinding may have occurred on a far wider scale. According to the trial’s design, unblinded staff were responsible for preparing and administering the study drug (Pfizer’s vaccine or a placebo). This was to be done to preserve the blinding of trial participants and all other site staff, including the principal investigator. However, at Ventavia, Jackson told The BMJ that drug assignment confirmation printouts were being left in participants’ charts, accessible to blinded personnel. As a corrective action taken in September, two months into trial recruitment and with around 1000 participants already enrolled, quality assurance checklists were updated with instructions for staff to remove drug assignments from charts.

In a recording of a meeting in late September2020 between Jackson and two directors a Ventavia executive can be heard explaining that the company wasn’t able to quantify the types and number of errors they were finding when examining the trial paperwork for quality control. “In my mind, it’s something new every day,” a Ventavia executive says. “We know that it’s significant.”

Ventavia was not keeping up with data entry queries, shows an email sent by ICON, the contract research organisation with which Pfizer partnered on the trial. ICON reminded Ventavia in a September 2020 email: “The expectation for this study is that all queries are addressed within 24hrs.” ICON then highlighted over 100 outstanding queries older than three days in yellow. Examples included two individuals for which “Subject has reported with Severe symptoms/reactions … Per protocol, subjects experiencing Grade 3 local reactions should be contacted. Please confirm if an UNPLANNED CONTACT was made and update the corresponding form as appropriate.” According to the trial protocol a telephone contact should have occurred “to ascertain further details and determine whether a site visit is clinically indicated.”

Worries over FDA inspection

Documents show that problems had been going on for weeks. In a list of “action items” circulated among Ventavia leaders in early August 2020, shortly after the trial began and before Jackson’s hiring, a Ventavia executive identified three site staff members with whom to “Go over e-diary issue/falsifying data, etc.” One of them was “verbally counseled for changing data and not noting late entry,” a note indicates.

LinkedIn censors interview with British cardiologist who criticized Pfizer vaccine data coverup

Source: https://www.infowars.com/posts/linkedin-censors-interview-with-british-cardiologist-who-criticized-pfizer-vaccine-data-coverup/

inkedIn has decided that a video about the efficacy of Covid vaccines, originally posted on YouTube and featuring Dr. Aseem Malhotra was violating its “professional community policies.”

Interviewer Maajid Nawaz posted a screenshot of the message he received from LinkedIn on Facebook, informing him of the removal and that only he can now see the post.

LBC presenter Maajid Nawaz discusses major concerns around vaccine mandates with Consultant Cardiologist Dr Aseem Malhotra who says the corporate capture of public health is at the root of the healthcare crisis

Data show excess mortality all around the world due to covid “vaccines”

Source: https://www.naturalnews.com/2021-11-11-data-shows-excess-mortality-covid-vaccines.html

(Natural News) Summer 2021 going into Fall 2021 is seeing a meteoric rise in all-cause mortality compared to that of the same time period in 2020. What changed? The “Operation Warp Speed” injections they are calling “vaccines” were rolled out all around the world.

Every country where jab uptake is high, including in Scotland, Israel, Denmark and the United States, is seeing a massive spike in deaths from things other than “covid.” The obvious culprit is the jabs, of course.

The Unz Review put together an extensive analysis of the available data, which clearly shows that all-cause mortality is “mooning,” so to speak. Records are being smashed in terms of death tolls, especially in areas of the world where large numbers of people took the injections.

In Scotland, for instance, the government recently logged the 20th consecutive week in which excess deaths throughout the country have exceeded the five-year average. This is in a country with an 87 percent jab compliance rate so far.

“Even excluding Covid deaths they were almost 20% above normal for the most recent week, and the trend is rising,” relayed Alex Berenson on his Substack.

Germany is in a similar quagmire with nearly 78,000 reported excess deaths, a figure 10 percent higher than what was expected.

“Mortality figures (in Germany) in September 2021: 10% above the median of previous years,” Berenson added.

More young people are dying from covid jabs than old people

In Denmark, Finland and Norway, “mystery” covid deaths are currently higher than ever before, even during the “worst” of the plandemic. The deaths really started spiking in these three countries immediately following the “vaccine” rollout.

For five months in a row, Denmark has shattered the 10-year record of people dying from “all causes.” Meanwhile, there have been basically zero deaths caused by “covid” during this time.

Ireland, the United Kingdom and Israel are all posting similar alarming figures. And it just so happens that all three of these countries have extremely high “vaccination” rates.

Interestingly, the worst-off demographic in all this is young people, who are dying at a much higher rate from the injections than the elderly. One would think that the opposite would be true.

“While the COVID death toll has been largely confined to the elderly … it’s the young who are bearing the brunt of vaccine injury,” reported LifeSiteNews, as relayed by Unz.

“According to VigiAccess, the adverse event database for the World Health Organization, 41% of the more than 2.4 million vaccine injuries reported so far are among those under age 44, and just six percent are among people over age 75.”

Whistleblower: Pfizer vaccine trial data was falsified, participants who experienced adverse effects were ignored

Source: https://www.naturalnews.com/2021-11-11-pfizer-falsified-trial-data-vaccine-adverse-effects.html

A private clinical research company involved in the Pfizer Wuhan coronavirus (COVID-19) vaccine trial in the fall of 2020 falsified phase-three trial data and neglected participants who experienced adverse events.

This is according to the testimony of whistleblower Brook Jackson, a clinical trial auditor with more than 15 years of experience in clinical research coordination and management. Jackson worked for Ventavia Research Group, a clinical research company based in Texas, for two weeks in Sept. 2020.

During her stint at Ventavia, Jackson repeatedly alerted her employer to the overwhelming number of problems in quality control of the trial. She even emailed her complaints to the Food and Drug Administration (FDA). But all of her concerns were ignored and her employer fired her on the same day she reported her concerns to the FDA.

Paul. D. Thacker, who handled the BMJ’s report on Jackson’s testimony, wrote that the medical journal is in possession of “dozens of internal company documents, photos, audio recordings and emails” – thanks to Jackson.

One of the photos in the BMJ’s possession reportedly shows “vaccine packaging materials with trial participants’ identification numbers written on them left out in the open, potentially unblinding participants.”

Keeping trials double-blind is an important aspect that maintains the integrity of randomized control trials. It protects data from being influenced by bias, and researchers dedicated to science and facts should at all times maintain the blinding of research facilitators and participants.

But when Jackson took the photo of the packaging materials, Ventavia executives questioned her and reprimanded her.

Patrick Delaney, writing for Life Site News, pointed out that some clinical research companies may have financial incentives to break research protocols and unblind participants to produce outcomes favorable to their clients. “In this case, Pfizer, and their knowledge of trial participants’ status may bias them in how they collect data,” he wrote.

According to Jackson’s email to the FDA, she had many other issues regarding Ventavia’s Pfizer trial, including:

• Post-injection participants were ignored by clinical staff.
• Patients who experienced adverse reactions to the vaccinations were not followed-up with on time.
• Protocol deviations were not being reported.
• Vaccines were not stored at proper temperatures.
• Laboratory specimens were routinely mislabeled.
• Ventavia executives harassed staff who reported concerns about the way the trial was conducted.